AI medicine

Profluent leverages AI for groundbreaking medicine discovery, supported by Salesforce research and investment from Jeff Dean. Main Points: Profluent’s Genesis: Stemming from Salesforce’s ProGen project, Profluent aims to transform the drug development process by designing custom-fit treatments using generative AI. Technology and Goals: By analyzing the language of proteins, ProfluentContinue Reading